Toxicological Research

  • 제41권1호
  • /
  • Pages.81-90
  • /
  • 2025
  • /
  • 1976-8257(pISSN)
  • /
  • 2234-2753(eISSN)
한국독성학회 (Korean Society of Toxicology & Korea Environmental Mutagen Society)
권호 표지
DOI QR코드

DOI QR Code

Quinine inhibits myogenic differentiation by disrupting AKT signaling pathway

  • Mi Ran Byun (Department of Pharmacy, Daegu Catholic University) ;
  • Sou Hyun Kim (Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University) ;
  • RanJu Woo (Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University) ;
  • Seung Jun Noh (Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University) ;
  • Sang Hoon Joo (Department of Pharmacy, Daegu Catholic University) ;
  • Young-Suk Jung (Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University) ;
  • Joon-Seok Choi (Department of Pharmacy, Daegu Catholic University)
  • 투고 : 2024.09.22
  • 심사 : 2024.12.02
  • 발행 : 2025.01.15
⟨ 이전 논문 다음 논문 ⟩

초록

Sarcopenia is a disease characterized by decreased muscle fibers and mass. Although it mainly affects the older adults, it can also occur in various age groups as a secondary effect of medications used for treating certain diseases, such as cancer and diabetes. With population aging, sarcopenia has drawn significant attention owing to its increasing prevalence. However, its pathogenesis remains unclear, and no specific treatment is available. Natural products containing bioactive compounds have long been used as therapeutic agents and are crucial sources for drug development. However, the use of drugs derived from natural extracts is limited because of their ambiguous mechanisms of action and potential side effects. Therefore, a systematic analysis of the potential effects of using natural products is required. In this study, we investigated the effects of the antimalarial drug quinine on myogenic differentiation. Our findings revealed that quinine significantly inhibited the expression of marker genes and proteins associated with myogenic differentiation and markedly impaired muscle regeneration following injury. Furthermore, this reduction occurred when quinine selectively decreased the AKT signaling activity. Quinine reduced muscle protein and gene expression by modulating AKT signaling and inhibiting myogenic differentiation and muscle regeneration. Therefore, quinine may cause sarcopenia, and this risk should be considered when using quinine for treatment.

키워드

과제정보

This work was supported by a 2-Year Research Grant of Pusan National University.

참고문헌

  1. Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990S-991S. https://doi.org/10.1093/jn/127.5.990
  2. Davis MP, Panikkar R (2019) Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Ann Palliat Med 8:86–101. https://doi.org/10.21037/apm.2018.08.02
  3. Mele A, Calzolaro S, Cannone G, Cetrone M, Conte D, Tricarico D (2014) Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle. Pharmacol Res Perspect 2:e00028. https://doi.org/10.1002/prp2.28
  4. Verdijk LB, Koopman R, Schaart G, Meijer K, Savelberg HH, van Loon LJ (2007) Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab 292:E151-157. https://doi.org/10.1152/ajpendo.00278.2006
  5. Verdijk LB, Snijders T, Drost M, Delhaas T, Kadi F, van Loon LJ (2014) Satellite cells in human skeletal muscle; from birth to old age. Age 36:545-547. https://doi.org/10.1007/s11357-013-9583-2
  6. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P (2001) Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 276:39264-39270. https://doi.org/10.1074jbc.M104991200 https://doi.org/10.1074jbc.M104991200
  7. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bau-erlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in V1VO. Nat Cell Biol 3:1014-1019. https://doi.org/10.1038/ncb1101-1014
  8. Montarras D, L'Honore A, Buckingham M (2013) Lying low but ready for action: the quiescent muscle satellite cell. FEBS J 280:4036-4050. https://doi.org/10.1111/febs.12372
  9. Grounds MD, Yablonka-Reuveni Z (1993) Molecular and cell biology of skeletal muscle regeneration. Mol Cell Biol Hum Dis Ser 3:210-256. https://doi.org/10.1007/978-94-011-1528-5_9
  10. Hawke TJ, Garry DJ (2001) Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91:534-551. https://doi.org/10.1152/jappl.2001.91.2.534
  11. Massenet J, Gardner E, Chazaud B, Dilworth FJ (2021) Epi-genetic regulation of satellite cell fate during skeletal muscle regeneration. Skeletal Muscle 11:4. https://doi.org/10.1186/s13395-020-00259-w
  12. Hernandez Hernandez JM, Garcia-Gonzalez EG, Brun CE, Rud-nicki MA (2017) The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration. Semin Cell Dev Biol 72:10-18. https://doi.org/10.1016/j.semcdb.2017.11,010
  13. Zammit PS (2017) Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis. Semin Cell Dev Biol 72:19-32. https://doi.org/10.1016j.semcdb.2017.11.011 https://doi.org/10.1016j.semcdb.2017.11.011
  14. Schiaffino S, Mammucari C (2011) Regulation of skeletal muscle growth by the IGFI-Akt/PKB pathway: insights from genetic models. Skeletal Muscle 1:4. https://doi.org/l0.1186/2044-5040-1-4 https://doi.org/10.1186/2044-5040-1-4
  15. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 75:59-72 https://doi.org/10.1016/S0092-8674(05)80084-4
  16. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617. https://doi.org/10.1101lgad.7.12b.2609 https://doi.org/10.1101lgad.7.12b.2609
  17. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195-200. https://doi.org/10.1038/84839
  18. Gardner S, Anguiano M, Rotwein P (2012) Defining Akt actions in muscle differentiation. Am J Physiol Cell Physiol 303:C1292-C1300. https://doi.org/10.1152/ajpcell.00259.2012
  19. Wilson EM, Rotwein P (2007) Selective control of skeletal muscle differentiation by Akt1. J Biol Chem 282:5106-5110. https://doi.org/10.1074/jbc.C600315200
  20. Druilhe P, Brandicourt O, Chongsuphajaisiddhi T, Berthe J (1988) Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 32:250-254. https://doi.org/10.1128/AAC.32.2.250
  21. Eyal S (2018) The fever tree: from malaria to neurological diseases. Toxins 10:491. https://loi.org/10.3390/toxins10120491
  22. Fardet L, Nazareth I. Petersen I (2017) Association between long-term quinine exposure and all-cause mortality. JAMA 317:1907-1909. https://doi.org/10.1001/jama.2017.2332
  23. Liu W, Qi Y, Liu L, Tang Y, Wei J, Zhou L (2016) Suppression of tumor cell proliferation by quinine Via the inhibition of the tumor necrosis factor receptor-associated factor 6-AKT interaction. Mol Med Rep 14:2171-2179. https://doi.org/10.3892/mmr.2016.5492
  24. Islahudin F, Tindall SM, Mellor IR, Swift K, Christensen HE, Fone KC, Pleass RJ, Ting KN, Avery SV (2014) The antimalarial drug quinine interferes with serotonin biosynthesis and action. Sci Rep 4:3618. https://doi.org/10.1038/srep03618
  25. Wilson EM, Hsieh MM, Rotwein P (2003) Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J Biol Chem 278:41109-41113. https://doi.org/10.1074/jbc.C300299200
  26. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotch-enko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ (2004) Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24:9295-9304. https://doi.org/10.1128/MCB.24.21.9295-9304.2004
  27. Rotwein P, Wilson EM (2009) Distinct actions of Aktland Akt2 in skeletal muscle differentiation. J Cell Physiol 219:503-511. https://doi.org/10.1002/jcp.21692
  28. Carlson BM, Faulkner JA (1983) The regeneration of skeletal muscle fibers following injury: a review. Med Sci Sports Exerc 15:187-198 https://doi.org/10.1249/00005768-198315030-00002
  29. Carlson BM (1973) The regeneration of skeletal muscle. A review. Am J Anat 137:119-149. https://doi.org/10.1002/ja.1001370202
  30. Hastings RL, Massopust RT, Haddix SG, Lee YI, Thompson WJ (2020) Exclusive vital labeling of myonuclei for studying myonuclear arrangement in mouse skeletal muscle tissue. Skeletal Muscle 10:15. https://doi.org/10.1186/s13395-020-00233-6
  31. Dias DA, Urban S, Roessner U (2012) A historical overview of natural products in drug discovery. Metabolites 2:303-336. https://doi.org/10.3390/metabo2020303
  32. Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, Rosenthal PJ, D'Alessandro U (2011) Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J 10:144. https://doi.org/10.1186/1475-2875-10-144
  33. Colley JC, Edwards JA, Heywood R, Purser D (1989) Toxicity studies with quinine hydrochloride. Toxicology 54:219-226. https://doi.org/10.1016/0300-483x(89)90047-4
  34. Flaks B (1978) Effects of chronic oral dosing with quinine sulphate in the rat. Pathol Res Pract 163:373-377. https://doi.org/10.1016/S0344-0338(78)80034-X
  35. Santilli V, Bernetti A, Mangone M, Paoloni M (2014) Clinical definition of sarcopenia. Clin Cases Miner Bone Metab 11:177-180 https://doi.org/10.11138/ccmbm/2014.11.3.177
  36. Kuzuya M (2024) Drug-related sarcopenia as a secondary sarcopenia. Geriatr Gerontol Int 24:195-203. https://doi.org/10.1111/ggi.14770
  37. Fry CS, Rasmussen BB (2011) Skeletal muscle protein balance and metabolism in the elderly. Curr Aging Sci 4:260-268. https://doi.org/10.2174/1874609811104030260
  38. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M (2013) Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 280:4294-4314. https://doi.org/10.1111/febs.12253